Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a type of blood cancer characterized by the uncontrolled clonal proliferation of myeloid hematopoietic progenitor cells in the bone marrow. The outcome of AML is poor, with five-year overall survival rates of less than 10% for the predominant group of patients older t...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Acker, Heleen H., Versteven, Maarten, Lichtenegger, Felix S., Roex, Gils, Campillo-Davo, Diana, Lion, Eva, Subklewe, Marion, Van Tendeloo, Viggo F., Berneman, Zwi N., Anguille, Sébastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572115/
https://www.ncbi.nlm.nih.gov/pubmed/31035598
http://dx.doi.org/10.3390/jcm8050579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572115/
https://www.ncbi.nlm.nih.gov/pubmed/31035598
http://dx.doi.org/10.3390/jcm8050579

Ejemplares similares